Maintenance Notice (8:45 AM - 1:00 PM February 22, 2025): This website is scheduled to be unavailable due to maintenance. We appreciate your patience and understanding.
Published TCIMAIL newest issue No.197 | New tool "TCI SpectraViewer" | [Product Highlights] Chemiluminescent Reagents for... | Product Document Searching Made Easy by 2D Code!
Maximum quantity allowed is 999
CAS RN: 145821-59-6 | Product Number: T3165
Tiagabine Hydrochloride

Purity: >99.0%(HPLC)
Size | Unit Price | Hyderabad | Japan* | Quantity |
---|---|---|---|---|
50MG |
₹4,600.00
|
1 | Contact Us |
|
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | T3165 |
Purity / Analysis Method | >99.0%(HPLC) |
Molecular Formula / Molecular Weight | C__2__0H__2__5NO__2S__2·HCl = 412.00 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Refrigerated (0-10°C) |
Store Under Inert Gas | Store under inert gas |
Condition to Avoid | Hygroscopic,Heat Sensitive |
CAS RN | 145821-59-6 |
Related CAS RN | 115103-54-3 |
Reaxys Registry Number | 6378452 |
PubChem Substance ID | 253662389 |
Merck Index (14) | 9417 |
MDL Number | MFCD07369025 |
Appearance | White to Light yellow powder to crystal |
Purity(HPLC) | min. 99.0 area% |
Purity(Neutralization titration) | min. 98.0 % |
Melting point | 189.0 to 194.0 °C |
Specific rotation [a]20/D | -9.0 to -12.0 deg(C=1, H2O) |
Melting Point | 193 °C |
Specific Rotation | -11° (C=1.0,H2O) |
Solubility in water | Soluble |
RTECS# | TM6128245 |
References
- The synthesis of novel GABA uptake inhibitors. 1. Elucidation of the structure-activity studies leading to the choice of (R)-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylic acid (Tiagabine) as an anticonvulsant drug candidate
- Tiagabine, SK and F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1
- Comparison of antiepileptic drugs tiagabine, lamotrigine, and gabapentin in mouse models of acute, prolonged, and chronic nociception
- Basic mechanisms of gabitril (tiagabine) and future potential developments (a review)
- Tiagabine (a review: development, mechanism of action, clinical pharmacokinetics, efficacy, adverse effects, drug interactions, clinical uses, and therapeutic potential.)
- Drug interactions involving the new second- and third-generation antiepileptic drugs
Articles/Brochures
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.